Boston BioProducts

Activities: Manufacturing Ingredients
Boston BioProducts

Trending Articles

  1. AmMax Bio licenses antibody-drug conjugate technology for haematological cancers from Lonza New agreement provides AmMax with access to Lonza’s GlycoConnect, HydraSpace, and SYNtecan linker-payload technologies | Agreement to target development of novel...
  2. You need to be a subscriber to read this article.
    Click here to find out more.
    Where nanoengineering meets drug formulation How Nanexa is turning short-acting drugs into long-acting injectables
  3. IMA MED-TECH launches ASSEMBLA modular assembly platform for medical devices across full lifecycle The engineer-to-order system scales from 20 to 500+ parts per minute on a single extendable frame, supporting injectables, inhalers, diagnostics and wearables from clinical...
  4. ACG Packaging Materials gains ISO 9001 and EN ISO 15378 certification for Croatia facility The dual-certified warehouse and slitting site strengthens ACG's European supply chain offer, bringing primary packaging materials production closer to customers amid growing...
  5. Why integrated outsourcing wins in modern drug development Aligning drug substance and drug product development within a single outsourcing model accelerates timelines, sharpens CMC decisions and reduces risk by enabling parallel...

Upcoming event

BIO International Convention

22–25 June 2026 | Convention | Boston, US See all

Related Content

Manufacturing
Boston BioProducts achieves ISO certification for QMS system

Boston BioProducts achieves ISO certification for QMS system

Achieving this certification signifies Boston BioProducts’ commitment to high-quality standards across the entire reagent manufacturing process
Subscribe now